Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Free Cash Flow (2023 - 2025)

CG Oncology filings provide 3 years of Free Cash Flow readings, the most recent being -$36.2 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 73.34% to -$36.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$132.4 million, a 67.75% decrease, with the full-year FY2025 number at -$132.4 million, down 67.75% from a year prior.
  • Free Cash Flow hit -$36.2 million in Q4 2025 for CG Oncology, up from -$39.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$8.0 million in Q1 2023 to a low of -$39.0 million in Q3 2025.
  • Median Free Cash Flow over the past 3 years was -$18.5 million (2024), compared with a mean of -$21.4 million.
  • Biggest five-year swings in Free Cash Flow: plummeted 225.87% in 2024 and later dropped 12.56% in 2025.
  • CG Oncology's Free Cash Flow stood at -$14.6 million in 2023, then crashed by 42.51% to -$20.9 million in 2024, then tumbled by 73.34% to -$36.2 million in 2025.
  • The last three reported values for Free Cash Flow were -$36.2 million (Q4 2025), -$39.0 million (Q3 2025), and -$27.9 million (Q2 2025) per Business Quant data.